Demystifying the Impact of COVID-19 Crisis on the Cannabis Industry: Hot Buttons
Recording Available: Friday, December 18, 2020
The COVID-19 pandemic brought unprecedented disruptions on many industries including the cannabis sector. Because of this, companies must always be wary of the crisis’s impact on tax, M&A transactions, and other industries affecting cannabis. Additionally, they must keep themselves updated with the significant enforcement actions from the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) in response to the increasing COVID-19 benefit claims.
Join a panel of key thought leaders and professionals assembled by The Knowledge Group as they delve into an in-depth discussion of the implications of COVID-19 on the cannabis industry. Speakers will also tackle emerging issues and risk mitigation strategies to ensure that they are positioned for success even during the pandemic.
Some of the major topics that will be covered in this course are:
- Cannabis Industry and the COVID-19
- Enforcement Trends and Developments
- Key Issues, Challenges, and Opportunities
- Practical Strategies and Best Practices
Who Should Attend:
- Cannabis Law Attorneys
- Cannabis Business Owners
- Regulatory and Policy Managers
- Legal and Compliance Executives
- Pharmaceutical/Medicinal Products Manufacturers
- In-House Counsel
- Senior Executives
Tim Bossidy is a Senior Director at SierraConstellation Partners with a significant track record of financial and operational consulting services to companies in transition. His advisory experience extends across turnaround management, mergers and acquisitions, capital raising and conducting financial modeling and forecasting across a variety of industries including: cannabis, consumer/retail, agriculture, media/entertainment, oil and gas, healthcare tech and healthcare services.
Prior to joining SCP, Tim worked as an investment banker at Goldman Sachs. There he focused on mergers and acquisitions, alongside initial public offerings, other equity transactions and debt financing. Prior to Goldman Sachs, Tim worked as a credit analyst at The Travelers Companies, where he covered high yield and investment grade bonds across the oil and gas and municipal sectors.
Tim holds a bachelor’s degree in economics and English from the University of Notre Dame and an MBA from Kellogg School of Management. He is originally from Connecticut and currently lives in Los Angeles.
Print and review course materials
Method of Presentation:
General knowledge of the Controlled Substances Act (CSA)
NY Category of CLE Credit:
Areas of Professional Practice
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
Get Your 1-Year All Access Pass For Only $199
About SierraConstellation Partners
SierraConstellation Partners (SCP) is a national interim management and advisory firm headquartered in Los Angeles with offices in Houston, Boston and New York and professionals in Dallas and Seattle. SCP serves middle-market companies and their partners and investors that are navigating their way through difficult business challenges. Our team’s real-world experience, operational mindset and hands-on approach enable us to deliver effective operational improvements and financial solutions to help companies restore value, regain creditor confidence, and capitalize on opportunities.
As former CEOs, COOs, CFOs, private equity investors and investment bankers, our team of senior professionals has decades of experience operating and advising companies. For more information, please visit www.sierraconstellation.com.